Canadian Agency for Drugs and Technologies in Health Appoints Public Member to its Health Technology Expert Review Panel
OTTAWA — The Canadian Agency for Drugs and Technologies in Health (CADTH) today announced the appointment of a Public Member to its recently established Health Technology Expert Review Panel. The Panel is an advisory body, convened to develop guidance and recommendations to CADTH on non-drug health technologies such as medical devices. The Panel consists of Core Members, who are appointed to serve for all topics under consideration, and Expert Members, who are appointed on a per-project basis, providing expertise on specific topics.
Dr. Brian O’Rourke, President and Chief Executive Officer of CADTH, is pleased to welcome Ms. Anita Fineberg, legal practitioner and consultant, Toronto, Ontario, as a Public Member to the Panel. She joins four other Core Members on this Panel, who were recently announced.
Ms. Fineberg has extensive experience in the health care field, specializing in the areas of privacy, access to information, data security, and information management law. Her practice focuses on health information privacy compliance and the use and protection of health information in the development of electronic medical and health records. She teaches Health Law at George Brown College and is a frequent speaker, workshop leader, and author on privacy and information security issues.
“Public representation on this Panel is critical to CADTH, as it promotes transparency and ensures that the voice of the public is brought to the table, reflecting the needs and values of Canadians,” said Dr. O’Rourke.
The Public Member represents the broader public interest, serving in the capacity as a member of the general public — not as a representative of any specific interest group or organization. The Public Member has full membership, with similar responsibilities and expectations, and is subject to the same terms and conditions as other Panel representatives.
About CADTH
The Canadian Agency for Drugs and Technologies in Health is an independent, not-for-profit organization funded by the federal, provincial, and territorial governments of Canada. CADTH is one of Canada’s leading sources of information and advice on the effectiveness and efficiency of drugs, medical devices, and other health technologies.
For more information:
Media Contacts:
Peter Chinneck, Director, Partnerships and Strategic Initiatives
Canadian Agency for Drugs and Technologies in Health
613-226-2553
peterc@cadth.ca
Janis Bogart, Communications Officer
Canadian Agency for Drugs and Technologies in Health
613-226-2553
janisb@cadth.ca